Home | | Site Map |
Screen resolution: 1024x768px | Auto width
Main Menu
Home
About PSS
eBulletin
Events Calendar
Community Chapter
News
Quick Links
Contact Us
Surveys
Pharmacist Blogs
Latest entries
None

Pharma & Healthcare News

Print E-mail

 •    Khazanah Won Control for Parkway; Fortis Bowed Out with Handsome Profits

We reported in our past issue about the tussle to control Parkway. The final verdict on 26-July confirmed that Malaysian state investor Khazanah trumped India's Fortis Healthcare in the fiercely fought takeover battle for Parkway Healthcare which runs a number other premium hospitals in Asia Pacific.

Both Fortis and Khazanah intended to embark on expansion in the region's booming healthcare market via Parkway, which runs hospitals in Singapore, Malaysia, India and China.


Khazanah -- in its biggest acquisition overseas -- said it was offering around S$3.95 (US$2.88) per share for all Parkway shares it does not own, or about 76%, topping the S$3.80 offered by Fortis. Fortis bows out in the process but pocketed a handsome profit of S$116.7 million profit on its Parkway stake to look for other opportunities. At the end of the day, Khazanah got its gem & Fortis smiled widely with some windfalls.

Shares of Fortis, controlled by the past Ranbaxy generic duo Malvinder & Shivinder Singh had surged more than 6% in Mumbai tock excahnge just ahead of Khazanah's confirmation. Analysts predict that the change in ownership won't make much difference to Parkway's future growth strategy or operations because Khazanah was already a large shareholder. Do you own Parkway shares...?

 

 

 

 

 

**********